NCT02259426View on ClinicalTrials.gov

Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2015

Conditions
MalariaAsymptomatic MalariaPlasmodium Falciparum
Interventions
DRUG

Dihydroartemisinin-piperaquine combination (Artekin)

DRUG

Primaquine

Single-dose 0.25mg/kg

Trial Locations (1)

30-40305

ICIPE, Mbita

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

collaborator

International Centre of Insect Physiology and Ecology (ICIPE)

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT02259426 - Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission | Biotech Hunter | Biotech Hunter